Armistice Capital »

Citi Trends shares owned by Armistice Capital

Quarter-by-quarter ownership of Citi Trends (CTRN) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Citi Trends

Tip: Access up to 7 years of quarterly data

All positions including Citi Trends held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Citi Trends by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.7M 29k 57.84

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Cytokinetics Com New (CYTK)
Agios Pharmaceuticals (AGIO)
Madrigal Pharmaceuticals (MDGL)
Ptc Therapeutics I (PTCT)
Supernus Pharmaceuticals (SUPN)
Travere Therapeutics (TVTX)
Immunovant (IMVT)
Incyte Corporation (INCY)
Neurocrine Biosciences (NBIX)
UnitedHealth (UNH)
Mineralys Therapeutics (MLYS)
Freshpet (FRPT)
Dyne Therapeutics (DYN)

View all positions for Armistice Capital

Top funds holding Citi Trends

Fund 1 Investments
Divisadero Street Capital Management
BlackRock
Dimensional Fund Advisors
Acadian Asset Management
Vanguard Capital Management
Royce & Associates
AQR Capital Management
Marshall Wace
Qube Research & Technologies
Goldman Sachs Group
Arrowstreet Capital, Limited Partnership
Driehaus Capital Management
Geode Capital Management
Burkehill Global Management

View all funds holding Citi Trends